S. Jeuring

发表

Cohort Profile Cohort Profile : The Inflammatory Bowel Disease South Limburg Cohort ( IBDSL )

M. Zeegers, D. Jonkers, M. Pierik, 2015 .

Corticosteroid Sparing in Inflammatory Bowel Disease is More Often Achieved in the Immunomodulator and Biological Era—Results from the Dutch Population-Based IBDSL Cohort

M. Zeegers, D. Jonkers, M. Pierik, 2018, The American Journal of Gastroenterology.

European Crohn's and Colitis Organisation Topical Review on IBD in the Elderly.

P. Gionchetti, F. Rizzello, S. Sebastian, 2016, Journal of Crohn's & colitis.

Improvements in the Long-Term Outcome of Crohn’s Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort

M. Zeegers, D. Jonkers, M. Pierik, 2017, The American Journal of Gastroenterology.

Classic drugs in the time of new drugs: real‐world, long‐term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease

D. Jonkers, A. V. van Bodegraven, M. Pierik, 2022, Alimentary pharmacology & therapeutics.

Temporal changes in the epidemiology, treatment and outcome of inflammatory bowel disease in South Limburg

S. Jeuring, 2019 .

Epidemiology and Long-term Outcome of Inflammatory Bowel Disease Diagnosed at Elderly Age—An Increasing Distinct Entity?

M. Zeegers, D. Jonkers, M. Pierik, 2016, Inflammatory bowel diseases.

Time trends in the epidemiology and outcome of perianal fistulizing Crohn's disease in a population-based cohort.

L. Stassen, D. Jonkers, S. Breukink, 2017, European journal of gastroenterology & hepatology.

Su1333 Disease Course, Phenotype, and Medication Use in Elderly-Onset Crohn's Disease Patients - A Population-Based IBD-SL Cohort Study

M. Zeegers, D. Jonkers, M. Pierik, 2015 .

A 20-Year Temporal Change Analysis in Incidence, Presenting Phenotype and Mortality, in the Dutch IBDSL Cohort—Can Diagnostic Factors Explain the Increase in IBD Incidence?

M. Zeegers, D. Jonkers, M. Pierik, 2017, Journal of Crohn's & colitis.

Disease Activity Patterns of Crohn’s Disease in the First Ten Years After Diagnosis in the Population-based IBD South Limburg Cohort

V. M. D. Martins dos Santos, D. Jonkers, E. Saccenti, 2020, Journal of Crohn's & colitis.

Disease Outcome of Ulcerative Colitis in an Era of Changing Treatment Strategies: Results from the Dutch Population-Based IBDSL Cohort.

L. Stassen, M. Zeegers, D. Jonkers, 2015, Journal of Crohn's & colitis.

Editorial: thiopurines in the multidrug era—time to rescue our memories over half a century of experience. Authors' reply

D. Jonkers, A. V. van Bodegraven, M. Pierik, 2022, Alimentary pharmacology & therapeutics.

Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population‐based IBDSL cohort

M. Zeegers, D. Jonkers, M. Pierik, 2016, International journal of cancer.

79 Disease Behavior in Crohn's Disease Patients Diagnosed in the Biological Era - A Dutch Population-Based IBD-SL Cohort Study

M. Zeegers, D. Jonkers, M. Pierik, 2015 .

Su1218 Concomitant Use of Immunomodulators Increases Long Term Response to Infliximab in Ulcerative Colitis - A Population-Based IBD-Sl Cohort Study

D. Jonkers, M. Pierik, L. Oostenbrug, 2013 .

Time trends in the epidemiology and outcome of perianal fistulizing Crohn's disease in a population-based cohort.

L. Stassen, D. Jonkers, S. Breukink, 2017, European journal of gastroenterology & hepatology.